Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a gentle oxygen boost make lung biopsies safer and faster?

NCT ID NCT07760727

Disease control Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether giving high-flow nasal oxygen during a sedated lung biopsy procedure (EBUS-TBNA) can reduce breathing complications like low oxygen levels and help patients recover more quickly. About 120 adults scheduled for this procedure will receive either high-flow or standard oxygen. Researchers will compare breathing problems, blood gas levels, and recovery times between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
High-flow nasal oxygen therapy
What this could lead to
If effective, high-flow nasal oxygen could become standard care during sedated EBUS-TBNA, lowering breathing risks and shortening recovery time.
What could go wrong
This is a single-center trial with 120 participants, so results may not apply broadly. High-flow oxygen may not reduce complications and could cause discomfort or other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (≥18 years) scheduled to undergo sedated endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) at Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital. Participants will be allocated to receive either high-flow nasal oxygen therapy or conventional oxygen therapy during the procedure

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age ≥18 years. Scheduled to undergo sedated EBUS-TBNA. Ability to provide written informed consent. ASA physical status I-III. Exclusion Criteria: * Age \<18 years. * Pregnancy. * Requirement for endotracheal intubation or general anesthesia. * Severe hemodynamic instability. * Refusal to participate in the study. * Contraindication to high-flow nasal oxygen therapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood gas analysis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood gas analysis Endobronchial ultrasound - transbronchial needle aspiration High flow oxygen therapy Sedation Sedation complication

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ankara Dr. Abdurrahman Yurtaslan Oncolgy Training and Research Hospital

    Ankara, Central, 0620, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.